Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

African migrants news

Show

From To
PrEP for African migrants in Europe? A research agenda

Clinical trials and demonstration projects in Europe have focused solely on men having sex with men (MSM). In contrast to global PrEP research, Europe seems to have overlooked heterosexuals at risk of HIV, mostly sub-Saharan African migrants and other ethnic minorities from endemic regions. Research should urgently investigate how to offer PrEP to all people in need: how to stimulate demand, how to deliver it, and how to support adherence.

Published
31 October 2016
From
The Lancet HIV (requires free registration)
The Lancet: Migrants screened for active tuberculosis pose negligible risk of spreading infection but can still get disease later

Tuberculosis incidence in the UK has declined over the past four years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves.

Published
13 October 2016
From
Eurekalert Medicine & Health
Promising trends continue in UK diagnosis and treatment rates

A ‘mini report’ of the latest figures on HIV diagnoses, late diagnosis, and treatment uptake in the UK reports generally good results, with downward trends in infections, the

Published
07 October 2016
By
Gus Cairns
Strong association between sexual violence and African women acquiring HIV in Europe

Migrant African women who have acquired HIV since moving to France are four times more likely to have experienced forced sex in France than other migrant women,

Published
19 July 2016
By
Roger Pebody
Sub-type C infection does not increase the risk of virologic failure when people are taking tenofovir-containing first-line ART

There is no evidence that HIV-positive people with sub-type C infection have an increased risk of treatment failure when receiving tenofovir-containing regimens, investigators from the UK report in

Published
08 June 2016
By
Michael Carter
NAT reaction to the Queen’s Speech 2016

At the State Opening of Parliament today, the Queen announced a Bill “to ensure that overseas visitors pay for the health treatment they receive at public expense”. She also stated that proposals will be now be brought forward for a British Bill of Rights.

Published
18 May 2016
From
NAT
Online privacy concerns limit the reach of sexual health messages on social media

The way in which individuals manage their identities on Facebook, for example avoiding publication of material which could be seen as revealing something about their sexual behaviour

Published
25 April 2016
By
Roger Pebody
African women in London with poor adherence feel that HIV treatment is difficult and unrelenting

A qualitative study with West African women living in London who have difficulties adhering to their HIV treatment has found that many think of HIV treatment as

Published
04 April 2016
By
Roger Pebody
What does the PrEP decision mean for heterosexuals?

NHS England recently announced it was pulling the plug on an 18 month process to decide whether or not to fund pre-exposure prophylaxis (PrEP) for HIV. While NHS England have offered a sop of £2 million funding to provide PrEP to 500 gay men over two years, there has been no mention of provision for heterosexual women and men at all, let alone those from African communities.

Published
02 April 2016
From
National AIDS Trust
Migrants on the NHS: 'You're targeted because you have an accent'

Mary was hit with a £5,000 bill after her son got meningitis. Campaigners say NHS staff are put in an impossible position when forced to decide on eligibility.

Published
07 March 2016
From
The Guardian

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.